![Gian Reverberi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gian Reverberi
Direktor/Vorstandsmitglied bei
SYNCONA LIMITED
Vermögen: 77 782 $ am 31.08.2026
Profil
Gian Piero Reverberi is currently an Independent Non-Executive Director at Syncona Ltd. since 2018 and Senior VP & Head-Global Gastroenterology at Ferring Pharmaceuticals.
Former roles include Chairman & Managing Director at Shire France SAS, Director-Diabetes Care Business at Eli Lilly Italia SpA, District Manager at Eli Lilly & Co. from 1999 to 2004, Chief Commercial Officer & Senior Vice President at Vanda Pharmaceuticals, Inc. from 2015 to 2020, Senior VP-International Specialty Pharma at Shire Pharmaceuticals, Inc. from 2006 to 2014, and General Manager at Shire Italia SpA from 2004 to 2006.
Education includes an undergraduate degree from Sapienza University of Rome in 1988 and an MBA from SDA Bocconi School of Management in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SYNCONA LTD GBP 0.01% | 31.03.2026 | 50’000 ( 0.01% ) | 77 782 $ | 31.08.2026 |
Aktive Positionen von Gian Reverberi
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNCONA LIMITED | Direktor/Vorstandsmitglied | 01.04.2018 |
Ehemalige bekannte Positionen von Gian Reverberi
| Unternehmen | Position | Ende |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Corporate Officer/Principal | 16.03.2020 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.03.2014 |
Shire Italia SpA
 Shire Italia SpA Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 01.06.2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.05.2004 |
Eli Lilly Italia SpA
 Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Gian Reverberi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Sapienza University of Rome
 Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shire Italia SpA
Shire Italia SpA Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Eli Lilly Italia SpA
Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shire France SAS
 Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SDA Bocconi School of Management
 SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
